Mon, October 3, 2022
Sun, October 2, 2022
Fri, September 30, 2022
Thu, September 29, 2022

Vikram Purohit Maintained (AXSM) at Hold with Decreased Target to $71 on, Sep 30th, 2022

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-decreased-target-to-71-on-sep-30th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication
Vikram Purohit of Morgan Stanley, Maintained "Axsome Therapeutics, Inc." (AXSM) at Hold with Decreased Target from $75 to $71 on, Sep 30th, 2022.

Vikram has made no other calls on AXSM in the last 4 months.



There are 5 other peers that have a rating on AXSM. Out of the 5 peers that are also analyzing AXSM, 0 agree with Vikram's Rating of Hold.



These are the ratings of the 5 analyists that currently disagree with Vikram


  • Graig Suvannavejh of "Mizuho" Initiated at Strong Buy and Held Target at $76 on, Wednesday, September 7th, 2022
  • Raghuram Selvaraju of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $210 on, Tuesday, August 23rd, 2022
  • Marc Goodman of "SVB Leerink" Maintained at Buy with Increased Target to $75 on, Monday, August 22nd, 2022
  • Charles Duncan of "Cantor Fitzgerald" Maintained at Buy with Increased Target to $64 on, Wednesday, June 29th, 2022
  • Joseph Thome of "Cowen & Co." Maintained at Buy with Increased Target to $130 on, Wednesday, June 29th, 2022